Adam Mendelsohn is Chief Executive Officer of SECOND SIGHT MEDICAL PRODUCTS INC. Currently has a direct ownership of 3.61 Million shares of EYES, which is worth approximately $0. The most recent transaction as insider was on Feb 08, 2023, when has been sold 17,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.61M
0% 3M change
0% 12M change
Total Value Held $0

Adam Mendelsohn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2023
SELL
Bona fide gift
-
17,000 Reduced 0.47%
3,605,015 Common Stock
Aug 30 2022
BUY
Other acquisition or disposition
-
3,622,015 Added 50.0%
3,622,015 Common Stock
AM

Adam Mendelsohn

Chief Executive Officer
Emeryville, CA

Track Institutional and Insider Activities on EYES

Follow SECOND SIGHT MEDICAL PRODUCTS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYES shares.

Notify only if

Insider Trading

Get notified when an Second Sight Medical Products Inc insider buys or sells EYES shares.

Notify only if

News

Receive news related to SECOND SIGHT MEDICAL PRODUCTS INC

Track Activities on EYES